INS and type 1 diabetes mellitus: On the other hand, in a multicentric population-based cohort study including patients with T1D<20 years of age, it has been shown that CSII therapy, compared with insulin injection therapy, was associated with lower risks of severe hypoglycemia and DKA and with better glycemic control during the most recent year of therapy [9].